Detalhe da pesquisa
1.
Therapeutic and prognostic insights from the analysis of cancer mutational signatures.
Trends Genet;
38(2): 194-208, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34483003
2.
Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia.
Blood;
135(1): 41-55, 2020 01 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31697823
3.
The landscape of coding RNA editing events in pediatric cancer.
BMC Cancer;
21(1): 1233, 2021 Nov 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34789196
4.
Therapy-induced mutagenesis in relapsed ALL is supported by mutational signature analysis.
Blood;
136(19): 2235-2237, 2020 11 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32688387
5.
Opposing effects of KDM6A and JDP2 on glucocorticoid sensitivity in T-ALL.
Blood Adv;
7(14): 3479-3484, 2023 07 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36897249
6.
Convergent evolution and multi-wave clonal invasion in H3 K27-altered diffuse midline gliomas treated with a PDGFR inhibitor.
Acta Neuropathol Commun;
10(1): 80, 2022 05 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35642016
7.
Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor.
Cell Genom;
2(11): None, 2022 Nov 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36388765
8.
The genomic landscape of pediatric acute lymphoblastic leukemia.
Nat Genet;
54(9): 1376-1389, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36050548
9.
Novel temporal and spatial patterns of metastatic colonization from breast cancer rapid-autopsy tumor biopsies.
Genome Med;
13(1): 170, 2021 10 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34711268
10.
A `one-two punch' therapy strategy to target chemoresistance in estrogen receptor positive breast cancer.
Transl Oncol;
14(1): 100946, 2021 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33221681
11.
Exploration of Coding and Non-coding Variants in Cancer Using GenomePaint.
Cancer Cell;
39(1): 83-95.e4, 2021 01 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33434514
12.
Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy.
Blood Cancer Discov;
2(4): 326-337, 2021 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34250504
13.
Chemotherapy and mismatch repair deficiency cooperate to fuel TP53 mutagenesis and ALL relapse.
Nat Cancer;
2(8): 819-834, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35122027
14.
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma.
Nat Commun;
12(1): 6468, 2021 11 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34753908
15.
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms.
Nat Commun;
12(1): 985, 2021 02 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33579957
16.
St. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing Ecosystem.
Cancer Discov;
11(5): 1082-1099, 2021 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33408242
17.
Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing.
Cancer Discov;
11(12): 3008-3027, 2021 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34301788
18.
Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations.
Nat Commun;
11(1): 5183, 2020 10 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33056981
19.
The Small GTPase ARF6 Activates PI3K in Melanoma to Induce a Prometastatic State.
Cancer Res;
79(11): 2892-2908, 2019 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31048499
20.
The Clonal Evolution of Metastatic Osteosarcoma as Shaped by Cisplatin Treatment.
Mol Cancer Res;
17(4): 895-906, 2019 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30651371